Although California's governor hoped to have the cheaper insulin available by last year, it may take at least another two years.
A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...
The company estimates that its install base surpassed 15,000 by the end of last year, leading to sales of more than $20 ...
Inc., the nonprofit drug manufacturer contracted to produce insulin for California, has not started clinical trials or applied for approval from the federal Food and Drug Administration, both of which ...
Continuous glucose monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose ...
Newsom’s insulin fail. A drive by California Gov. Gavin Newsom to make low-cost insulin by spending $100 million in state ...
The final proposed model would have had Medicare pay less for drugs that receive accelerated approvals from the Food and Drug ...
Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a newer class of drugs used to treat diabetes, have recently been ...